Human cytomegalovirus US3 modulates destruction of MHC class I molecules

Molecular Immunology

Volumn 51, Issue 2, 2012, Pages 245-253

  Noriega, Vanessa M ^a   Hesse, Julia ^b   Gardner, Thomas J ^a   Besold, Katrin ^b,c   Plachter, Bodo ^b   Tortorella, Domenico ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Antigen presentation; HCMV US3 and US11; Immune modulation; MHC class I molecules; Proteasome degradation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOMODULATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; VIRUS INFECTION;

CELL LINE; CYTOMEGALOVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; GENES, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84860358453     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2012.03.024     Document Type: Article

References (31)

1. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10990-10995.
2. Andreoni M., Faircloth M., Vugler L., Britt W.J. A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J. Virol. Methods 1989, 23:157-167.
3. Barel M.T., Pizzato N., Le Bouteiller P., Wiertz E.J., Lenfant F. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. Int. Immunol. 2006, 18:173-182.
4. Besold K., Frankenberg N., Pepperl-Klindworth S., Kuball J., Theobald M., Hahn G., Plachter B. Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion. J. Gen. Virol. 2007, 88:1429-1439.
5. Besold K., Wills M., Plachter B. Immune evasion proteins gpUS2 and gpUS11 of human cytomegalovirus incompletely protect infected cells from CD8T cell recognition. Virology 2009, 391:5-19.
6. Cherepanov P.P., Wackernagel W. Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 1995, 158:9-14.
7. Furman M.H., Dey N., Tortorella D., Ploegh H.L. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J. Virol. 2002, 76:11753-11756.
8. Jackson S.E., Mason G.M., Wills M.R. Human cytomegalovirus immunity and immune evasion. Virus Res. 2010, 157:151-160.
9. Kleijnen M.F., Huppa J.B., Lucin P., Mukherjee S., Farrell H., Campbell A.E., Koszinowski U.H., Hill A.B., Ploegh H.L. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J. 1997, 16:685-694.
10. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., Jenkins N.A., Copeland N.G. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 2001, 73:56-65.
11. Lilley B.N., Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004, 429:834-840.
12. Lilley B.N., Tortorella D., Ploegh H.L. Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer. Mol. Biol. Cell 2003, 14:3690-3698.
13. Liu S.Y., Sanchez D.J., Cheng G. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 2011, 23:57-64.
14. Loenen W.A., Bruggeman C.A., Wiertz E.J. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 2001, 13:41-49.
15. Mocarski E. Betaherpes viral genes and their functions. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007, Cambridge University Press, Cambridge, Chapter 15. A. Arvin, G. Campadelli-Fiume, E. Mocarski, P.S. Moore, B. Roizman, R. Whitley, K. Yamanishi (Eds.).
16. Noriega, V., Redmann, V., Gardner, T., Tortorella, D., 2012. Diverse immune evasion strategies by human cytomegalovirus. Immunol. Res. In Press.
17. Noriega V.M., Tortorella D. A bipartite trigger for dislocation directs the proteasomal degradation of an endoplasmic reticulum membrane glycoprotein. J. Biol. Chem. 2008, 283:4031-4043.
18. Noriega V.M., Tortorella D. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules. J. Virol. 2009, 83:1359-1367.
19. Park B., Kim Y., Shin J., Lee S., Cho K., Fruh K., Ahn K. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 2004, 20:71-85.
20. Park B., Lee S., Kim E., Cho K., Riddell S.R., Cho S., Ahn K. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 2006, 127:369-382.
21. Pinto A.K., Munks M.W., Koszinowski U.H., Hill A.B. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J. Immunol. 2006, 177:3225-3234.
22. Powers C., DeFilippis V., Malouli D., Fruh K. Cytomegalovirus immune evasion. Curr. Top. Microbiol. Immunol. 2008, 325:333-359.
23. Reusch U., Muranyi W., Lucin P., Burgert H.G., Hengel H., Koszinowski U.H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 1999, 18:1081-1091.
24. Tortorella D., Gewurz B., Schust D., Furman M., Ploegh H. Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology. Immunol. Invest. 2000, 29:97-100.
25. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., Ploegh H.L. Viral subversion of the immune system. Ann. Rev. Immunol. 2000, 18:861-926.
26. Trgovcich J., Cebulla C., Zimmerman P., Sedmak D.D. Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression. J. Virol. 2006, 80:951-963.
27. Wagner M., Gutermann A., Podlech J., Reddehase M.J., Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 2002, 196:805-816.
28. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996, 84:769-779.
29. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
30. Yu D., Smith G.A., Enquist L.W., Shenk T. Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene. J. Virol. 2002, 76:2316-2328.
31. Ziegler H., Muranyi W., Burgert H.G., Kremmer E., Koszinowski U.H. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules. EMBO J. 2000, 19:870-881.